| Literature DB >> 27206868 |
Leonela N Luce1, Viviana Dalamon2, Marcela Ferrer3, Diana Parma4, Irene Szijan4, Florencia Giliberto4.
Abstract
Dystrophinopathies are X-linked recessive diseases caused by mutations in the DMD gene. Our objective was to identify mutations in this gene by Multiplex Ligation Probe Amplification (MLPA), to confirm the clinical diagnosis and determine the carrier status of at-risk relatives. Also, we aimed to characterize the Dystrophinopathies argentine population and the DMD gene. We analyzed a cohort of 121 individuals (70 affected boys, 11 symptomatic women, 37 at-risk women and 3 male villus samples). The MLPA technique identified 56 mutations (45 deletions, 9 duplications and 2 point mutations). These results allowed confirming the clinical diagnosis in 63% (51/81) of patients and symptomatic females. We established the carrier status of 54% (20/37) of females at-risk and 3 male villus samples. We could establish an association between the most frequent deletion intron breakpoints and the abundance of dinucleotide microsatellites loci, despite the underlying mutational molecular mechanism remains to be elucidated. The MLPA demonstrate, again, to be the appropriate first mutation screening methodology for molecular diagnosis of Dystrophinopathies. The reported results permitted to characterize the Dystrophinopathies argentine population and lead to better understanding of the genetic and molecular basis of rearrangements in the DMD gene, useful information for the gene therapies being developed.Entities:
Keywords: Carrier detection; Duchenne Muscular Dystrophy; Dystrophinopathies; Gene characterization; MLPA analysis; Molecular diagnosis
Mesh:
Substances:
Year: 2016 PMID: 27206868 DOI: 10.1016/j.jns.2016.03.047
Source DB: PubMed Journal: J Neurol Sci ISSN: 0022-510X Impact factor: 3.181